tiprankstipranks
Advertisement
Advertisement

Convatec AGM backs all resolutions as investors flag concern on pay

Story Highlights
  • Convatec’s AGM saw all proposed resolutions approved, including accounts, dividend and capital authorities.
  • Investor support for Convatec’s remuneration report was weaker, prompting further shareholder engagement on pay.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Convatec AGM backs all resolutions as investors flag concern on pay

Meet Samuel – Your Personal Investing Prophet

ConvaTec ( (GB:CTEC) ) has shared an update.

Convatec shareholders approved all resolutions at the company’s annual general meeting in London, including the 2025 accounts, a dividend, auditor appointment and authorities for share issuance, buybacks and shorter notice for general meetings. One resolution, to re-elect former non-executive director Professor Constantin Coussios, was withdrawn following his resignation in April.

The board acknowledged that support for the remuneration report was significantly weaker than for other items, with only about two-thirds of votes cast in favour. Convatec pledged further engagement with investors and proxy advisers on pay, promising to report within six months on the outcome, underscoring ongoing shareholder scrutiny of executive compensation and governance at the FTSE 100 medical devices group.

The most recent analyst rating on (GB:CTEC) stock is a Buy with a £375.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.

Spark’s Take on CTEC Stock

According to Spark, TipRanks’ AI Analyst, CTEC is a Neutral.

The score is driven primarily by solid underlying financial performance (growth, improving operating margins, positive free cash flow) and supportive guidance for continued growth and margin expansion. This is tempered by increased leverage and notable operational/regulatory risks flagged on the call, while valuation looks expensive and technicals appear near overbought despite an uptrend.

To see Spark’s full report on CTEC stock, click here.

More about ConvaTec

Convatec Group is a global medical products and technologies company focused on managing chronic conditions, with leading positions in advanced wound care, ostomy care, continence care and infusion care. It serves around 90 countries, employs more than 10,000 people, generated over $2 billion in revenue in 2025, and is a constituent of the FTSE 100 index.

Average Trading Volume: 11,267,112

Technical Sentiment Signal: Sell

Current Market Cap: £4.18B

See more data about CTEC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1